MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

15.59 2.3

Resumen

Variación precio

24h

Actual

Mínimo

15.15

Máximo

15.89

Métricas clave

By Trading Economics

Ingresos

-70M

-67M

Ventas

-2.1M

20M

P/B

Media del Sector

48.528

37.257

Rentabilidad por dividendo

0.48

Margen de beneficios

-330.585

Empleados

243

EBITDA

-79M

-74M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+12.31% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.94%

Próximas Ganancias

22 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-41M

311M

Apertura anterior

13.29

Cierre anterior

15.59

Noticias sobre sentimiento de mercado

By Acuity

7%

93%

8 / 371 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 oct 2025, 22:33 UTC

Ganancias

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 oct 2025, 22:21 UTC

Principales Movimientos del Mercado

Dentsply Sirona Shares Rise After SEC Probe Ends

14 oct 2025, 19:27 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 oct 2025, 17:56 UTC

Principales Movimientos del Mercado

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 oct 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 oct 2025, 22:12 UTC

Charlas de Mercado
Ganancias

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 oct 2025, 21:40 UTC

Ganancias

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 oct 2025, 21:39 UTC

Ganancias

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 oct 2025, 21:38 UTC

Ganancias

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 oct 2025, 21:06 UTC

Ganancias

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 oct 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

14 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 oct 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

14 oct 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Health Care Roundup: Market Talk

14 oct 2025, 20:13 UTC

Ganancias

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 oct 2025, 20:01 UTC

Ganancias

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 oct 2025, 19:21 UTC

Charlas de Mercado
Ganancias

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 oct 2025, 19:12 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 oct 2025, 19:08 UTC

Charlas de Mercado

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 oct 2025, 19:02 UTC

Charlas de Mercado

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 oct 2025, 18:59 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 oct 2025, 18:58 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 oct 2025, 18:58 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 oct 2025, 18:56 UTC

Adquisiciones, fusiones, absorciones

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 oct 2025, 18:46 UTC

Ganancias

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 oct 2025, 18:04 UTC

Ganancias

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 oct 2025, 18:01 UTC

Charlas de Mercado

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 oct 2025, 17:54 UTC

Ganancias

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 oct 2025, 17:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 oct 2025, 17:50 UTC

Charlas de Mercado

Lower Dollar Provides Some Strength in Grains -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

12.31% repunte

Estimación a 12 Meses

Media 17.33 USD  12.31%

Máximo 20 USD

Mínimo 16 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

3

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

8 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat